表紙
市場調査レポート

ドライアイ症候群の予測:主要7市場

Dry Eye Syndrome Forecast in 7 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339840
出版日 ページ情報 英文 36 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
ドライアイ症候群の予測:主要7市場 Dry Eye Syndrome Forecast in 7 Major Markets 2015-2025
出版日: 2015年09月01日 ページ情報: 英文 36 Pages
概要

ドライアイ症候群は涙液層の障害で、涙液減少 (ATD) かマイボーム腺機能不全 (MGD) 、あるいはその両方によって引き起こされるケースもあります。

当レポートでは、主要7市場 (米国、フランス、ドイツ、イタリア、スペイン、英国、日本) におけるドライアイ症候群の現在の患者数 (性別、年齢コホート別) について調査分析し、現在の有病率のほか、疾患の概要、危険因子、疾患の診断と予後、主な症状や合併症など、体系的な情報を提供しています。

図表

イントロダクション

病因

危険因子と予防

疾患の診断

変異:地域/民族別

疾患予後と臨床経過

疾患に関連する主な合併症/特徴

患者数を定量化する手法

ドライアイ症候群の有病率トップライン

ドライアイ症候群の主な合併症と特徴

  • 患者におけるドライアイ症候群のタイプ
  • ATDを認めるドライアイ症候群患者におけるシェーグレン症候群の存在
  • ドライアイ症候群患者におけるMGDの重症度
  • ドライアイ症候群患者におけるシェーグレン症候群のタイプ
  • ドライアイ症候群患者における共通の診断検査結果
  • ドライアイ症候群患者における合併症の有病率

略語

関連出版

患者ベースのオンラインデータベース

患者ベースの製品

価格のオンラインデータ・プラットフォーム

参考文献

付録

目次
Product Code: DRYE0010915

Dry Eye Syndrome is a disorder of the tear film which is caused by Aqueous Tear Deficiency (ATD) (insufficient tear production) or by Meibomian Gland Dysfunction (MGD) (excessive tear evaporation), or in some cases patients have both conditions. Inflammation of the ocular surface and the lachrymal glands are observed in patients. This report provides the current prevalent population for Dry Eye Syndrome across 7 Major Markets (USA, France, Germany, Italy, Spain, UK and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Dry Eye Syndrome. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Dry Eye Syndrome have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Dry Eye Syndrome include:

  • Glaucoma
  • Diabetes
  • Hypertension
  • Rheumatoid Arthritis
  • Sjorgen's Syndrome
  • Dry Mouth

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Dry Eye Syndrome's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Dry Eye Syndrome and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Dry Eye Syndrome's prevalent population.
  • Identify sub-populations within Dry Eye Syndrome which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Dry Eye Syndrome patients.

Coverage

US, UK, FR, DE, IT, ES, JP

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis &Clinical Course

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Dry Eye Syndrome

Main Complications and Features of Dry Eye Syndrome

  • Type of Dry Eye Syndrome in Patients
  • The Presence of Sjorgens Syndrome in Dry Eye Syndrome Patients with ATD
  • Severity of MGD in Dry Eye Syndrome Patients
  • The Type of Sjorgens Syndrome Present in Dry Eye Syndrome Patients
  • Common Diagnostic Test Results of Dry Eye Syndrome Patients
  • Prevalence of Co-morbidities in Dry Eye Syndrome Patients

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables & Figures

  • Prevalence of Dry Eye Syndrome, total (000s)
  • Prevalence of Dry Eye Syndrome, males (000s)
  • Prevalence of Dry Eye Syndrome, females (000s)
  • Dry Eye Syndrome by Type, total (000s)
  • Prevalence of ATD Type Dry Eye Syndrome Patients with or without Sjorgens Syndrome, total (000s)
  • Severity of MGD in Dry Eye Syndrome patients, total (000s)
  • Type of SS Present in Dry Eye Patients Suffering from SS, total (000s)
  • Severity of Corneal Staining, total (000s)
  • Tear Production of Dry Eye Syndrome Patients, total (000s)
  • TBUT of Dry Eye Syndrome Patients, total (000s)
  • Prevalence of Glaucoma in Dry Eye Syndrome patients, total (000s)
  • Prevalence of Diabetes in Dry Eye Syndrome patients, total (000s)
  • Prevalence of Hypertension in Dry Eye Syndrome patients, total (000s)
  • Prevalence of Rheumatoid Arthritis in Dry Eye Syndrome patients, total (000s)
  • Prevalence of Dry Mouth Symptoms in Dry Eye Syndrome patients, total (000s)
  • Abbreviations and Acronyms used in the Report
  • USA Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • USA Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • France Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • France Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • Germany Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • Germany Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • Italy Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • Italy Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • Spain Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • Spain Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
  • Japan Prevalence of Dry Eye Syndrome by 5-yr age cohort, males (000s)
  • Japan Prevalence of Dry Eye Syndrome by 5-yr age cohort, females (000s)
Back to Top